title: Quality by design approach: application of artificial intelligence techniques of tablets manufactured by direct compression.
abstract: The publication of the International Conference of Harmonization (ICH) Q8, Q9, and Q10 guidelines paved the way for the standardization of quality after the Food and Drug Administration issued current Good Manufacturing Practices guidelines in 2003. "Quality by Design", mentioned in the ICH Q8 guideline, offers a better scientific understanding of critical process and product qualities using knowledge obtained during the life cycle of a product. In this scope, the "knowledge space" is a summary of all process knowledge obtained during product development, and the "design space" is the area in which a product can be manufactured within acceptable limits. To create the spaces, artificial neural networks (ANNs) can be used to emphasize the multidimensional interactions of input variables and to closely bind these variables to a design space. This helps guide the experimental design process to include interactions among the input variables, along with modeling and optimization of pharmaceutical formulations. The objective of this study was to develop an integrated multivariate approach to obtain a quality product based on an understanding of the cause-effect relationships between formulation ingredients and product properties with ANNs and genetic programming on the ramipril tablets prepared by the direct compression method. In this study, the data are generated through the systematic application of the design of experiments (DoE) principles and optimization studies using artificial neural networks and neurofuzzy logic programs.
authors.affiliation: Santa Farma Pharmaceuticals, Borucicegi sok. No: 16 Sisli, Istanbul, Okmeydani, Turkey. baksu@santafarma.com.tr
authors.forename: Buket
authors.initials: B
authors.lastname: Aksu
authors.forename: Anant
authors.initials: A
authors.lastname: Paradkar
authors.forename: Marcel
authors.initials: M
authors.lastname: de Matas
authors.forename: Ozgen
authors.initials: O
authors.lastname: Ozer
authors.forename: Tamer
authors.initials: T
authors.lastname: Güneri
authors.forename: Peter
authors.initials: P
authors.lastname: York
mesh_terms: D001185:Artificial Intelligence; D002626:Chemistry, Pharmaceutical / Q000379:methods* / Q000592:standards; D004339:Drug Compounding / Q000379:methods* / Q000592:standards; D004345:Drug Industry / Q000379:methods* / Q000592:standards; D016571:Neural Networks, Computer; D011786:Quality Control; D012107:Research Design / Q000592:standards*; D013607:Tablets / Q000737:chemistry* / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D013607:Tablets